A meta-analysis of randomized double-blind clinical trials in CMT1A to assess the change from baseline in CMTNS and ONLS scales after one year of treatment

CMT1A is the most common inherited peripheral neuropathy. There is currently no approved treatment. We performed a meta-analysis including four randomized, double-blind, Placebo-controlled clinical trials to assess the disease progression after one year under Placebo, Ascorbic Acid (AA) or PXT3003,...

Celý popis

Podrobná bibliografie
Hlavní autoři: Mandel, Jonas, Bertrand, Viviane, Lehert, Philippe, Attarian, Shahram, Magy, Laurent, Micallef, Joëlle, Chumakov, Ilya, Scart-Grès, Catherine, Guedj, Mickael, Cohen, Daniel
Médium: Online Článek Text
Jazyk:English
Vydáno: BioMed Central 2015
Témata:
Letter to the Editor
On-line přístup:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4482281/
https://www.ncbi.nlm.nih.gov/pubmed/26070802
http://dx.doi.org/10.1186/s13023-015-0293-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4482281/
https://www.ncbi.nlm.nih.gov/pubmed/26070802
http://dx.doi.org/10.1186/s13023-015-0293-y

Podobné jednotky